Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Latest News & Press Releases |
|
|
|
|
Australia begins production of Oxford Covid-19 vaccine, plans to manufacture 30 million doses.
A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the...
|
| |
| |
|
Cancer Treatment Can Be Cloned For COVID-19.
As per the recent international study by the scientists from Italy & Australia, Beta-blockers have it in them to be a potential treatment for COVID-19....
|
|
|
|
| | |
| |
|
|
|
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To Adverse Incident.
Brazil's health regulator halted clinical trials of the potential coronavirus vaccine CoronaVac, citing an adverse, serious event, according to a statement..
|
|
| | | | |
| |
|
Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up For It?
For long India has been known to supply the world with pharmaceuticals at a very reasonable price. With that being said, immediately our focus turns..
|
|
|
|
|
| |
|
|
|
Thermo Fisher & Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China.
Thermo Fisher announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China...
|
|
|
| |
| |
|
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report.
The global contact services sector is benefiting from a switch towards COVID-19 manufacturing and clinical stage contracts, but mega-cap innovator...
|
|
|
|
| | |
|
| |
|
|
|
The Falling Graph of Dose Contract Manufacturing.
One could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in 2020...
|
|
| | | | |
| |
|
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA.
Novavax announced that the U.S. FDA has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.
|
|
|
|
|
| |
|
|
|
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study.
Pfizer and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy...
|
|
|
| |
|
A New Senate & its implications on The Pharmaceutical Sector?
The US elections make big news whenever they occur. The fact that who comes to power has a phenomenal effect on all industries, big or small....
|
|
|
|
|